Ipilimumab vs Ondansetron
Ipilimumab vs Ondansetron: Overview
This comparison examines the pharmacological differences between Ipilimumab and Ondansetron.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Ondansetron: Selective 5-HT3 receptor antagonist.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Ondansetron β 3-5 hours.
Chemical Properties
Molecular Formula: Ondansetron β C18H19N3O.
Molecular Weight: Ondansetron β 293.3660 g/mol.
Type: Ipilimumab β Antibody; Ondansetron β Small molecule.